ThermoFisher Scientific and Immundiagnostik announce collaboration on the development of novel LC-MS/MS tests
Combination of sophisticated antibody technology and modern mass specktroscopy delivers new assays
Thermo Fisher Scientific and Immundiagnostik will jointly develop novel mass spectrometry-based assays for research and clinical routine. The collaboration will focus on the identification of relevant biomarkers for the diagnostics of cardiovascular diseases and bone metabolism disorders. The assays will combine Immundiagnostik's ImmuTube® antibody technology with ThermoFisher's innovative LC-MS/MS analytics.